BioSpace News Archive

Pear Therapeutics, Inc. today announced that Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1 at 12:10 p.m. Eastern Time.

Imago BioSciences, Inc. (“Imago”) a clinical-stage biopharmaceutical company developing innovative treatments for myeloproliferative neoplasms, today announced its participation in the Piper Sandler 32nd Annual Healthcare Conference to be held virtually December 1 – 3, 2020.

Minovia Therapeutics, a clinical-stage company focused on the development of cell-based Mitochondrial Augmentation Therapy (MAT) to treat mitochondrial diseases, announced today a major expansion of its physical and organizational cGMP US manufacturing capability through a collaboration with BioSpherix, a specialized cell therapy equipment manufacturer

LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the 32nd Annual Piper Sandler Virtual Healthcare Conference

Halo Labs, a life science instrumentation company developing tools for biologics researchers, announced today that Rick Gordon has been named Chief Executive Officer

GE Healthcare today announced a new artificial intelligence (AI) algorithm to help clinicians assess Endotracheal Tube (ETT) placements, a necessary and important step when ventilating critically ill COVID-19 patients.

ALR Technologies Inc., the diabetes management company, is pleased to announce the clearance of the ALRT Diabetes Solution software by Health Canada.

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing a drug to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, castration-resistant prostate cancer and leukemia, today announced that the Company will be participating in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference.

Surgalign Holdings, Inc., a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, announced the appointment of Paul Lewicki, PhD as a member of its board of directors.

Collaboration with the Radiological Society of North America and American College of Radiology to demonstrate Common Data Elements support at the RSNA annual meeting